Hyperthyroxinemia, dystransthyretinemic

Synonyms: Dystransthyretinemic euthyroidal hyperthyroxinemia; EUTHRYROIDAL HYPERTHYROXINEMIA 2; HYPERTHYROXINEMIA, DYSPREALBUMINEMIC

Summary

Dystransthyretinemic hyperthyroxinemia (DTTRH) is characterized by an increased affinity for thyroxine (T4) by transthyretin in clinically euthyroid individuals (summary by Moses et al., 1990). [from OMIM]

Available tests

43 tests are in the database for this condition.

Clinical tests (43 available)

Molecular Genetics Tests

Genes See tests for all associated and related genes

Associated genes Help
Genes reported to contribute to the condition.

TTR
29 tests
Also known as: ATTR, CTS, CTS1, HEL111, HsT2651, PALB, TBPA, TTN, TTR
Summary: transthyretin

Imported from Human Phenotype Ontology (HPO)

Show all Hide all

Abnormality of the endocrine system
- Euthyroid hyperthyroxinemia
  Euthyroid hyperthyroxinemia
  - MedGen UID: 867191
  - Concept ID: C4021549
  - Finding: Disease or Syndrome
  Abnormality of the endocrine system
  See: Feature record | Search on this feature

Reviews

Clinical resources

Molecular resources

Consumer resources

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.